Virginia 2024 Regular Session

Virginia House Bill HB93

Introduced
12/30/23  
Refer
12/30/23  
Report Pass
1/25/24  
Refer
1/25/24  
Report Pass
2/5/24  
Engrossed
2/8/24  
Refer
2/12/24  
Report Pass
2/22/24  
Report Pass
2/29/24  
Enrolled
3/25/24  
Chaptered
4/4/24  

Caption

Alpha-gal syndrome; Board of Health shall adopt regulations to include on reportable disease list.

Impact

The inclusion of alpha-gal syndrome in the reportable diseases list is expected to lead to improved tracking of the disease's prevalence and incidence across Virginia. This change will empower health authorities to gather essential data that can inform public health strategies and resource allocation. With the increase in reported cases, there may be an uptick in research funding and initiatives aimed at understanding and combating the syndrome better. Ultimately, this legislative measure fosters a proactive approach to public health regarding tick-borne illnesses.

Summary

House Bill 93 (HB93) in Virginia aims to include alpha-gal syndrome in the list of reportable diseases as mandated by the Board of Health. This legislative action is a response to the growing awareness and cases of the syndrome, which is a condition caused by a reaction to the bite of certain ticks. By incorporating this condition into the reporting requirements, the state intends to enhance public health monitoring and responses to cases, thereby facilitating better health outcomes for affected individuals.

Sentiment

The overall sentiment surrounding HB93 appears to be positive, with unanimous support demonstrated in the Senate passage, where it was passed with a vote of 40-0. This reflects a collaborative recognition among legislators regarding the importance of public health, particularly in relation to emerging diseases like alpha-gal syndrome. The bill's aims to protect public health are likely to resonate well with both the medical community and the general public.

Contention

While there may be broad agreement on the need for better health regulations relating to tick-borne diseases, it's essential to recognize potential limitations in funding or resources necessary for the effective implementation of this bill. Questions may arise regarding how adequately state health departments will address the increased reporting needs whilst maintaining oversight over other diseases. Nevertheless, as it stands, the bill is viewed positively as a necessary enhancement to disease monitoring protocols in Virginia.

Companion Bills

No companion bills found.

Previously Filed As

VA HB1917

Public pools; Board of Health to adopt regulations.

VA SB1475

Board of Health; regulations.

VA HJR544

Alzheimer's Disease; Joint Commission on Health, etc., to study treatment.

VA HB2293

Emergency Services and Disaster Law; emergency orders and regulations, limitations, civil penalty.

VA HB2008

Tick-borne diseases; VDH to study reducing occurrence & impact.

VA SB948

Pharmacist scope of practice; initiation of treatment for certain diseases and conditions.

VA HB2274

Pharmacist scope of practice; initiation of treatment for certain diseases and conditions.

VA HB2086

Sickle Cell Disease, Advisory Council on; established, report.

VA HB2158

DMAS; Department shall evaluate its ability to comply with certain federal regulations.

VA SB1544

Licensed providers; DBHDS shall review its regulations relating to required reporting.

Similar Bills

No similar bills found.